Hu, Qili
Shi, Mengqiu
Li, Yunfei
Zhao, Xiaohu
Funding for this research was provided by:
Shanghai Science and Technology Commission, “Science and Technology Innovation Action Plan” project in the field of laboratory animal research (NO.201409002200, NO.201409002200, NO.201409002200, NO.201409002200)
the Minhang District Speciality Discipline Programme (NO.2020MWFC01, NO.2020MWFC01, NO.2020MWFC01, NO.2020MWFC01)
Key Medical Speciality funded by Shanghai Fifth People’s Hospital, Fudan University (NO.2020WYZDZK09, NO.2020WYZDZK09, NO.2020WYZDZK09, NO.2020WYZDZK09)
the Minhang District Natural Science Research Project Application/Project Assignment (NO. 2023MHZ036, NO. 2023MHZ036, NO. 2023MHZ036, NO. 2023MHZ036)
Article History
Received: 10 February 2024
Accepted: 14 June 2024
First Online: 6 July 2024
Declarations
:
: Ethical approval was not provided for this study on human participants because data used in the preparation of this article were obtained from the ADNI. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) was approved by the institutional review boards of all participating ADNI sites reviewed and approved the data collection protocol provided by ADNI. Ethics approval was obtained from the institutional review boards of each institution involved: Oregon Health and Science University; University of Southern California; University of California—San Diego; University of Michigan; Mayo Clinic, Rochester; Baylor College of Medicine; Columbia University Medical Center; Washington University, St. Louis; University of Alabama at Birmingham; Mount Sinai School of Medicine; Rush University Medical Center; Wien Center; Johns Hopkins University; New York University; Duke University Medical Center; University of Pennsylvania; University of Kentucky; University of Pittsburgh; University of Rochester Medical Center; University of California, Irvine; University of Texas Southwestern Medical School; Emory University; University of Kansas, Medical Center; University of California, Los Angeles; Mayo Clinic, Jacksonville; Indiana University; Yale University School of Medicine; McGill University, Montreal-Jewish General Hospital; Sunnybrook Health Sciences, Ontario; U.B.C. Clinic for AD & Related Disorders; Cognitive Neurology—St. Joseph’s, Ontario; Cleveland Clinic Lou Ruvo Center for Brain Health; Northwestern University; Premiere Research Inst (Palm Beach Neurology); Georgetown University Medical Center; Brigham and Women’s Hospital; Stanford University; Banner Sun Health Research Institute; Boston University; Howard University; Case Western Reserve University; University of California, Davis—Sacramento; Neurological Care of CNY; Parkwood Hospital; University of Wisconsin; University of California, Irvine—BIC; Banner Alzheimer’s Institute; Dent Neurologic Institute; Ohio State University; Albany Medical College; Hartford Hospital, Olin Neuropsychiatry Research Center; Dartmouth-Hitchcock Medical Center; Wake Forest University Health Sciences; Rhode Island Hospital; Butler Hospital; UC San Francisco; Medical University South Carolina; St. Joseph’s Health Care Nathan Kline Institute; University of Iowa College of Medicine; Cornell University; and University of South Florida: USF Health Byrd Alzheimer’s Institute. For up-to-date information, see .
: Not applicable.
: The authors declare that they have no competing interests.